BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1912756)

  • 1. Costs of bone marrow transplants using unrelated donors.
    Chapman JR; Atkinson K; Lapsley H
    Blood Rev; 1991 Jun; 5(2):112-6. PubMed ID: 1912756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unrelated-donor marrow transplants: the experience of the National Marrow Donor Program.
    Perkins HA; Kollman C; Howe CW
    Clin Transpl; 1994; ():295-301. PubMed ID: 7547550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Problems and possible solutions in finding an unrelated bone marrow donor. Results of consecutive searches for 240 Dutch patients.
    Oudshoorn M; Cornelissen JJ; Fibbe WE; de Graeff-Meeder ER; Lie JL; Schreuder GM; Sintnicolaas K; Willemze R; Vossen JM; van Rood JJ
    Bone Marrow Transplant; 1997 Dec; 20(12):1011-7. PubMed ID: 9466272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program.
    Kernan NA; Bartsch G; Ash RC; Beatty PG; Champlin R; Filipovich A; Gajewski J; Hansen JA; Henslee-Downey J; McCullough J
    N Engl J Med; 1993 Mar; 328(9):593-602. PubMed ID: 8429851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Australian Bone Marrow Donor Registry: cost-effectiveness and ethnic considerations.
    Martin C; Smyth L; Christiansen F; Edwards E; Dawkins R
    Transplant Proc; 1992 Oct; 24(5):2030. PubMed ID: 1412959
    [No Abstract]   [Full Text] [Related]  

  • 6. Unrelated volunteer bone marrow transplantation: initial experience at St Vincent's Hospital, Sydney.
    Atkinson K; Dodds AJ; Concannon AJ; Milliken S; Downs K; Marshall G; Wilson F; Staniforth D
    Aust N Z J Med; 1993 Oct; 23(5):450-7. PubMed ID: 8297273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unrelated and HLA-nonidentical related donor marrow transplantation for thalassemia and leukemia. A combined report from the Seattle Marrow Transplant Team and the International Bone Marrow Transplant Registry.
    Sullivan KM; Anasetti C; Horowitz M; Rowlings PA; Petersdorf EW; Martin PJ; Clift RA; Walters MC; Gooley T; Sierra J; Anderson JE; Bjerke J; Siadak M; Flowers ME; Nash RA; Sanders JE; Appelbaum FR; Storb R; Hansen JA
    Ann N Y Acad Sci; 1998 Jun; 850():312-24. PubMed ID: 9668553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost analysis of HLA-identical sibling and voluntary unrelated allogeneic bone marrow and peripheral blood stem cell transplantation in adults with acute myelocytic leukaemia or acute lymphoblastic leukaemia.
    van Agthoven M; Groot MT; Verdonck LF; Löwenberg B; Schattenberg AV; Oudshoorn M; Hagenbeek A; Cornelissen JJ; Uyl-de Groot CA; Willemze R
    Bone Marrow Transplant; 2002 Aug; 30(4):243-51. PubMed ID: 12203141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Report of the Japanese Central Bone Marrow Data Center.
    Tanaka H; Akaza T; Juji T
    Clin Transpl; 1996; ():139-44. PubMed ID: 9286563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unrelated donor marrow transplantation in Japan.
    Mori M
    Int J Hematol; 1996 Aug; 64(2):85-6. PubMed ID: 8854565
    [No Abstract]   [Full Text] [Related]  

  • 11. Unrelated bone marrow transplantation in Canada, the national experience.
    Buskard NA; Smiley RK; Perrault RA; Messner H
    Bone Marrow Transplant; 1991; 7 Suppl 1():44-8. PubMed ID: 2043885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of CML with unrelated donor marrow transplant.
    McGlave P
    Leuk Lymphoma; 1993; 11 Suppl 1():209-11. PubMed ID: 8251898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The South African bone marrow registry (SABMR) in 2004.
    du Toit ED; Borrill V; Schlaphoff TE
    Transfus Apher Sci; 2005 Feb; 32(1):25-6. PubMed ID: 15737870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Regulatory problems regarding bone marrow transplantation from non-consanguinous donors].
    Moratti A
    Ann Ist Super Sanita; 1999; 35(1):51-4. PubMed ID: 10645645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Search for bone marrow donors for patients with hematologic-oncologic diseases].
    Holzberger G; Seidl S; Kühnl P
    Beitr Infusionsther; 1990; 26():214-6. PubMed ID: 1703834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of cost analysis in the evaluation of the development of medical technology. The case of allogenic stem-cell transplantation].
    Groot MT; van Agthoven M; Löwenberg B; Willemze R; Uyl-de Groot CA
    Ned Tijdschr Geneeskd; 2004 Mar; 148(10):480-4. PubMed ID: 15042895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of a regional bone marrow donor program.
    McCullough J; Scott EP; Halagan N; Strand RA; McGlave P
    JAMA; 1988 Jun; 259(22):3286-9. PubMed ID: 3286909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The first-year costs of establishing an unrelated bone marrow donor registry.
    Larson EB; Chestnut TM; Beatty PG; Slichter S
    Transfusion; 1990 Feb; 30(2):138-41. PubMed ID: 2305442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow transplants using volunteer donors--recommendations and requirements for a standardized practice throughout the world. The Executive Committee of the World Marrow Donor Association.
    Bone Marrow Transplant; 1992 Sep; 10(3):287-91. PubMed ID: 1422482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unrelated-donor marrow transplants: the experience of the National Marrow Donor Program.
    Beatty PG; Kollman C; Howe CW
    Clin Transpl; 1995; ():271-7. PubMed ID: 8794273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.